Article
Generation and Evaluation of Clade C Simian-Human Immunodeficiency Virus Challenge Stocks
4 Dec 2014
Abstract excerpt
UNLABELLED: The development of a panel of mucosally transmissible simian-human immunodeficiency virus (SHIV) challenge stocks from multiple virus clades would facilitate preclinical evaluation of candidate HIV-1 vaccines and therapeutics. The majority of SHIV stocks that have been generated to date have been derived from clade B HIV-1 env sequences from viruses isolated during chronic infection and typically...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
